The disclosure concerns 2-carbamide-4-phenylthiazole derivatives of general formula (I). The disclosure also concerns pharmaceutical compositions containing a compound of general formula (I) and to processes for preparing and methods of using compounds of general formula (I).
该披露涉及通式(I)的2-
氨基甲酰胺-
4-苯基噻唑衍
生物。该披露还涉及含有通式(I)化合物的药物组合物,以及制备通式(I)化合物的方法和使用方法。